Research And Development
Europe
Health

AstraZeneca

1,783

$47.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+0.15%) Today
$0.00 (0.00%) As of 4:44 PM EST after-hours

Why Robinhood?

You can buy or sell AstraZeneca and other stocks, options, ETFs, and crypto commission-free!

About AZN

AstraZeneca PLC, also called AstraZeneca, is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Read More Its pipeline consists of azd 4831, azd 8601, medi 6012, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta. The company distributes its products under the following brands: Atacand, Crestor, Onglyza, Nexium, Entocort, Losec, Merrem/Meronem, Carbocaine, Citanest, Diprivan, Marcaine/Sensorcaine. AstraZeneca was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

CEO
Pascal Soriot
Employees
64,400
Headquarters
Cambridge, Cambridgeshire
Founded
1992
Market Cap
124.47B
Price-Earnings Ratio
59.03
Dividend Yield
3.61
Average Volume
2.88M
High Today
$47.53
Low Today
$46.82
Open Price
$46.84
Volume
2.28M
52 Week High
$49.22
52 Week Low
$35.30

Collections

Research And Development
Europe
Health
Manufacturing
Cancer Prevention
Biotechnology
Medical
Biopharmaceutical

AZN News

ReutersNov 11

AstraZeneca succeeds in treating lupus in late-stage study

The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8,
26
ReutersNov 11

UK Stocks-Factors to watch on Nov. 11

Nov 11 (Reuters) - Britain's FTSE 100 index is seen opening 3 points lower at 7,357 on Monday, according to financial bookmakers. * BHP: BHP Group's petroleum d
17

AZN Earnings

$0.29
$0.72
$1.15
$1.58
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Available Feb 13, Pre-Market

You May Also Like

SLYG
TANNI
INFU
CEMI
SCE-J
AHC
RCKT
PHD
JIH=
DYB
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy AZN

Market Price$47.44
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell AstraZeneca stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up